Skip to main content
. 2017 Sep 4;3(4):FSO244. doi: 10.4155/fsoa-2017-0079

Figure 5. . Example images of a circulating tumor cell isolated from a breast cancer patient.

Figure 5. 

Blood from the patient was processed for CTC enrichment using the ClearCell® FX system. The sample was then analyzed by chipcytometry and a single CTC determined to be PD-L1/PD-L2 negative was detected.

CTC: Circulating tumor cell.